Sea Moss for Sjogren's Syndrome: Fucoidan, Moisture Support, and Autoimmune Modulation

Sjogren's syndrome is a systemic autoimmune condition in which lymphocytes attack exocrine glands (salivary and lacrimal), causing dry eyes, dry mouth, fatigue, and systemic manifestations affecting 4 million Americans. Discover how sea moss fucoidan modulates the aberrant B-cell and T-cell activation driving glandular destruction, how its mucilaginous polysaccharides support mucosal moisture throughout the GI and respiratory tract, how its selenium content protects glandular epithelium from oxidative stress (selenium deficiency is common in Sjogren's and correlates with disease activity), how omega-3 precursors reduce tear film inflammation relevant to dry eye disease, and how its prebiotic effects support the microbiome-immune axis relevant to autoimmunity. Critical: Sjogren's requires rheumatologist management; primary Sjogren's can be associated with non-Hodgkin lymphoma (5-10% lifetime risk) requiring monitoring; sea moss is supplemental nutritional support only.

For the complete science-backed breakdown, including mechanisms, dosing, timing, and safety considerations, read our full guide:

Sea Moss for Sjogren's Syndrome: Fucoidan, Moisture Support, and Autoimmune Modulation

Key topics covered:

  • The specific compounds in sea moss relevant to this condition
  • Mechanistic pathways (not just anecdotal claims)
  • Evidence-based dosing protocols and timing
  • Drug interactions and contraindications
  • How to integrate with conventional medical care
  • What results are realistic and on what timeline

Read the full guide